Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy

Silvia Sánchez-Ramón (1) , Juan Carlos Ravell (1) , Inmaculada Torre (2) , María Montoro (2) , Margarita Rodríguez-Mahou (1) , Luis Carreño-Pérez (2) , Eduardo Fernández-Cruz (1) , Francisco Javier López-Longo (2)

1 Department of Immunology
2 Department of Rheumatology

We report on a 44-year-old woman affected by dermatopolymyositis resistant to conventional therapies who experienced long-term clinical improvement and remission after treatment with intravenous polyvalent immunoglobulin in a weekly schedule followed by rituximab therapy.

Mots clés: Dermatopolymyositis; Polyvalent immunoglobulin; Anti-CD20; Immunotherapy

Silvia Sánchez-Ramón, Juan Carlos Ravell, Inmaculada Torre, María Montoro, Margarita Rodríguez-Mahou, et al.. Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy. Rheumatology International, 2009, 30 (6), pp.817-819. ⟨10.1007/s00296-009-1000-x⟩. ⟨hal-00568297⟩